Literature DB >> 22383571

Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?

Spyros A Papiris, Effrosyni D Manali, Likourgos Kolilekas, Christina Triantafillidou, Iraklis Tsangaris, Konstantinos Kagouridis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22383571     DOI： 10.1164/ajrccm.185.5.587

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice.

Authors:  Alessandro Venosa; Jeremy Katzen; Yaniv Tomer; Meghan Kopp; Sarita Jamil; Scott J Russo; Surafel Mulugeta; Michael F Beers
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

Review 2.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis.

Authors:  Katy M Roach; Amanda Sutcliffe; Laura Matthews; Gill Elliott; Chris Newby; Yassine Amrani; Peter Bradding
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 4.  Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?

Authors:  Alessandro Marchioni; Roberto Tonelli; Lorenzo Ball; Riccardo Fantini; Ivana Castaniere; Stefania Cerri; Fabrizio Luppi; Mario Malerba; Paolo Pelosi; Enrico Clini
Journal:  Crit Care       Date:  2018-03-23       Impact factor: 9.097

5.  Conducting trials on corticosteroid dosing for respiratory failure in the last paradise.

Authors:  Nobuaki Shime
Journal:  J Intensive Care       Date:  2018-11-20

6.  Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?

Authors:  Sandra Cuerpo; Jorge Moisés; Fernanda Hernández-González; Mariana Benegas; Jose Ramirez; Marcelo Sánchez; Àlvar Agustí; Jacobo Sellares
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

7.  Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri.

Authors:  Virginia A Folcik; Michela Garofalo; Jack Coleman; James J Donegan; Elazar Rabbani; Saul Suster; Allison Nuovo; Cynthia M Magro; Gianpiero Di Leva; Gerard J Nuovo
Journal:  Mod Pathol       Date:  2013-11-15       Impact factor: 7.842

Review 8.  Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis.

Authors:  Emily Hams; Rachel Bermingham; Padraic G Fallon
Journal:  Front Immunol       Date:  2015-11-23       Impact factor: 7.561

9.  Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

Authors:  Spyros A Papiris; Konstantinos Kagouridis; Likurgos Kolilekas; Andriana I Papaioannou; Aneza Roussou; Christina Triantafillidou; Katerina Baou; Katerina Malagari; Stylianos Argentos; Anastasia Kotanidou; Anna Karakatsani; Effrosyni D Manali
Journal:  BMC Pulm Med       Date:  2015-12-14       Impact factor: 3.317

Review 10.  The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Paolo Spagnolo; Philip L Molyneaux; Nicol Bernardinello; Elisabetta Cocconcelli; Davide Biondini; Federico Fracasso; Mariaenrica Tiné; Marina Saetta; Toby M Maher; Elisabetta Balestro
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.